Immix Biopharma, Inc. (IMMX) earnings
IMMX earnings moved a median of +0.96% by the close. Quarterly and annual IMMX reports and results, each read against the price at its own news timestamp. Back to the IMMX overview →
15 measured IMMX earnings events.
Where these IMMX earnings landedvs 14 measured IMMX earnings reactions
| Middle 50% of IMMX earnings reactions | -0.58% to +3.59% |
|---|---|
| Median reaction (to close) | +0.96% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 IMMX earnings events with a measured close landed between -0.58% and +3.59%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Immix Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.90% | — | |
| Form 10-Q Immix Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.53% | +4.05% | |
| Form 10-K/A Immix Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.43% | +4.76% | |
| Form 10-K Immix Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +6.70% | +7.26% | |
| Form 10-Q Immix Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.68% | -0.61% | |
| Form 10-Q Immix Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.15% | -2.93% | |
| Form 10-K/A Immix Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +0.96% | |
| Form 10-Q/A Immix Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | +0.96% | |
| Form 10-Q Immix Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.67% | -0.48% | |
| Form 10-K Immix Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +2.21% | |
| Form 10-Q Immix Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -7.10% | |
| Form 10-Q Immix Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.54% | |
| Form 10-Q Immix Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +7.77% | +5.83% | |
| Form 10-K Immix Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.58% | |
| Form 10-Q Immix Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.95% | +1.19% |
Keep exploring
More IMMX: analyst actions → · SEC filings → · IMMX overview →